Mediation of in vivo glucose sensor inflammatory response via nitric oxide release.

In vivo glucose sensor nitric oxide (NO) release is a means of mediating the inflammatory response that may cause sensor/tissue interactions and degraded sensor performance. The NO release (NOr) sensors were prepared by doping the outer polymeric membrane coating of previously reported needle-type electrochemical sensors with suitable lipophilic diazeniumdiolate species. The Clarke error grid correlation of sensor glycemia estimates versus blood glucose measured in Sprague-Dawley rats yielded 99.7% of the points for NOr sensors and 96.3% of points for the control within zones A and B (clinically acceptable) on Day 1, with a similar correlation for Day 3. Histological examination of the implant site demonstrated that the inflammatory response was significantly decreased for 100% of the NOr sensors at 24 h. The NOr sensors also showed a reduced run-in time of minutes versus hours for control sensors. NO evolution does increase protein nitration in tissue surrounding the sensor, which may be linked to the suppression of inflammation. This study further emphasizes the importance of NO as an electroactive species that can potentially interfere with glucose (peroxide) detection. The NOr sensor offers a viable option for in vivo glucose sensor development.

[1]  Randy S. Lewis,et al.  Nitric Oxide, Superoxide, and Peroxynitrite Effects on the Insulin Secretion and Viability of βTC3 Cells , 2004, Annals of Biomedical Engineering.

[2]  D. Cox,et al.  Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose , 1987, Diabetes Care.

[3]  N. Wisniewski,et al.  Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue effects. , 2001, Journal of biomedical materials research.

[4]  U. Tantry,et al.  Nitric oxide metabolism in wounds. , 1997, The Journal of surgical research.

[5]  P. Efron,et al.  Diabetes-impaired healing and reduced wound nitric oxide synthesis: a possible pathophysiologic correlation. , 1997, Surgery.

[6]  J. Jansen,et al.  Performance of subcutaneously implanted glucose sensors for continuous monitoring. , 1999, The Netherlands journal of medicine.

[7]  Takehisa Matsuda,et al.  In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. , 2003, Journal of biomedical materials research. Part A.

[8]  A. L. Hart,et al.  Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part IV: phosphate buffer dependence , 1999 .

[9]  S. Moncada,et al.  ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM , 1987, The Lancet.

[10]  E. Ongini,et al.  Attenuation of chronic neuroinflammation by a nitric oxide‐releasing derivative of the antioxidant ferulic acid , 2004, Journal of neurochemistry.

[11]  M. Meyerhoff,et al.  More lipophilic dialkyldiamine-based diazeniumdiolates: synthesis, characterization, and application in preparing thromboresistant nitric oxide release polymeric coatings. , 2003, Journal of medicinal chemistry.

[12]  D. Feinstein,et al.  Intrinsic Regulation of Brain Inflammatory Responses , 2003, Cellular and Molecular Neurobiology.

[13]  C. Albanesi,et al.  Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo. , 2002, The American journal of pathology.

[14]  P. Vonk,et al.  Microdialysis of Glucose in Subcutaneous Adipose Tissue up to 3 Weeks in Healthy Volunteers , 1998, Diabetes Care.

[15]  Mark E. Meyerhoff,et al.  Preparation and characterization of implantable sensors with nitric oxide release coatings , 2003 .

[16]  M. Grisham,et al.  Reactive Nitrogen and Oxygen Species Attenuate Interleukin- 8-induced Neutrophil Chemotactic Activity in Vitro * , 2000, The Journal of Biological Chemistry.

[17]  M. Ozsoz,et al.  Electrochemical Detection of NO by Inhibition on Oxidase Activity , 2000 .

[18]  U Fischer,et al.  Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality? , 1992, Journal of biomedical engineering.

[19]  G. S. Wilson,et al.  Elimination of the acetaminophen interference in an implantable glucose sensor. , 1994, Analytical chemistry.

[20]  G. S. Wilson,et al.  Calibration of a subcutaneous amperometric glucose sensor implanted for 7 days in diabetic patients. Part 2. Superiority of the one-point calibration method. , 2002, Biosensors & bioelectronics.

[21]  G. S. Wilson,et al.  Design and in vitro studies of a needle-type glucose sensor for subcutaneous monitoring. , 1991, Analytical chemistry.

[22]  Jae Ho Shin,et al.  Nitric oxide-releasing sol-gel particle/polyurethane glucose biosensors. , 2004, Analytical chemistry.

[23]  Mark E Meyerhoff,et al.  Improved planar amperometric nitric oxide sensor based on platinized platinum anode. 1. Experimental results and theory when applied for monitoring NO release from diazeniumdiolate-doped polymeric films. , 2004, Analytical chemistry.

[24]  G Reach,et al.  Use of a subcutaneous glucose sensor to detect decreases in glucose concentration prior to observation in blood. , 1996, Analytical chemistry.

[25]  G. S. Wilson,et al.  In vitro and in vivo evaluation of oxygen effects on a glucose oxidase based implantable glucose sensor , 1993 .

[26]  J. Coleman Nitric oxide: a regulator of mast cell activation and mast cell‐mediated inflammation , 2002, Clinical and experimental immunology.

[27]  F Moussy,et al.  In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. , 2002, Journal of biomedical materials research.

[28]  G. S. Wilson,et al.  Calibration of a subcutaneous amperometric glucose sensor. Part 1. Effect of measurement uncertainties on the determination of sensor sensitivity and background current. , 2002, Biosensors & bioelectronics.

[29]  B. Cuthbertson,et al.  Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury , 2000, Critical care medicine.

[30]  G. Girolomoni,et al.  Regulatory role of nitric oxide on monocyte-derived dendritic cell functions. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[31]  M. Meyerhoff,et al.  Spontaneous catalytic generation of nitric oxide from S-nitrosothiols at the surface of polymer films doped with lipophilic copperII complex. , 2003, Journal of the American Chemical Society.

[32]  M. Alterman,et al.  Proteomic identification of age-dependent protein nitration in rat skeletal muscle. , 2003, Free radical biology & medicine.

[33]  James M. Anderson,et al.  Chapter 4 Mechanisms of inflammation and infection with implanted devices , 1993 .

[34]  Wisniewski,et al.  Methods for reducing biosensor membrane biofouling. , 2000, Colloids and surfaces. B, Biointerfaces.

[35]  Christian Bogdan,et al.  Nitric oxide and the immune response , 2001, Nature Immunology.

[36]  P. Smith,et al.  Proteins and lipids define the diffusional field of nitric oxide. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[37]  N Wisniewski,et al.  Characterization of implantable biosensor membrane biofouling , 2000, Fresenius' journal of analytical chemistry.

[38]  R. Ornberg,et al.  Modification of inflammatory response to implanted biomedical materials in vivo by surface bound superoxide dismutase mimics. , 2000, Journal of biomedical materials research.

[39]  G. Rao,et al.  Histologic evaluation of the inflammatory response around implanted hollow fiber membranes. , 2000, Journal of biomedical materials research.

[40]  S Moncada,et al.  The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. , 1987, Biochemical and biophysical research communications.

[41]  G Reach,et al.  Continuous glucose monitoring in the free-moving rat. , 1998, Metabolism: clinical and experimental.